📰 Nasdaq Bcab News
Nasdaq Bcab News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Nasdaq Bcab. Real-time updates on events, politics, business and more.
December 18, 2023
BioAtla, Inc. (NASDAQ:BCAB – Get Free Report) was the target of a significant increase in short interest in November. As of November 30th, there was short interest totalling 4,450,000 shares, an increase of 8.0% from the November 15th total of 4,120,000 shares. Based on an average daily trading volume, of 408,600 shares, the days-to-cover ratio […]
December 9, 2023
JMP Securities reiterated their market outperform rating on shares of BioAtla (NASDAQ:BCAB – Free Report) in a research note issued to investors on Tuesday morning, Benzinga reports. JMP Securities currently has a $12.00 price target on the stock. A number of other equities research analysts have also recently commented on BCAB. JPMorgan Chase & Co. […]
November 8, 2023
BioAtla (NASDAQ:BCAB – Get Free Report) had its price objective lowered by stock analysts at HC Wainwright from $17.00 to $10.00 in a research report issued to clients and investors on Tuesday, Benzinga reports. The brokerage currently has a “buy” rating on the stock. HC Wainwright’s price objective points to a potential upside of 468.18% […]
October 27, 2023
BioAtla, Inc. (NASDAQ:BCAB – Get Free Report) has been assigned an average rating of “Moderate Buy” from the six brokerages that are currently covering the stock, MarketBeat reports. One analyst has rated the stock with a hold rating and five have given a buy rating to the company. The average 12 month price target among […]
October 2, 2023
BioAtla, Inc. (NASDAQ:BCAB – Get Free Report) has been given a consensus rating of “Moderate Buy” by the six research firms that are currently covering the firm, MarketBeat reports. One research analyst has rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average twelve-month target price […]
August 6, 2023
JMP Securities restated their market outperform rating on shares of BioAtla (NASDAQ:BCAB – Free Report) in a research note released on Wednesday, Benzinga reports. They currently have a $12.00 price target on the stock. Other research analysts have also recently issued research reports about the stock. EF Hutton Acquisition Co. I restated a buy rating […]
July 18, 2023
BioAtla, Inc. (NASDAQ:BCAB – Get Free Report) saw a significant growth in short interest during the month of June. As of June 30th, there was short interest totalling 4,620,000 shares, a growth of 25.9% from the June 15th total of 3,670,000 shares. Based on an average daily volume of 531,100 shares, the short-interest ratio is […]
June 24, 2023
Shares of BioAtla, Inc. (NASDAQ:BCAB – Get Rating) have received a consensus recommendation of “Moderate Buy” from the six research firms that are presently covering the firm, MarketBeat.com reports. One equities research analyst has rated the stock with a hold rating and five have issued a buy rating on the company. The average 1-year price […]
May 30, 2023
BioAtla, Inc. (NASDAQ:BCAB – Get Rating) has been given an average rating of “Moderate Buy” by the six ratings firms that are covering the firm, MarketBeat reports. One research analyst has rated the stock with a hold rating and four have given a buy rating to the company. The average 12-month price target among brokers […]
May 30, 2023
BioAtla, Inc. (NASDAQ:BCAB – Get Rating) was the target of a large decline in short interest in the month of May. As of May 15th, there was short interest totalling 3,590,000 shares, a decline of 5.0% from the April 30th total of 3,780,000 shares. Based on an average trading volume of 499,900 shares, the short-interest […]